Saturday 17 October 2026
Export MAIA’s income statement to Excel — free account
MAIA Biotechnology, Inc.
MAIA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 27.8% and free cash flow fell 63.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.10
0.02
−1.79%
Follow MAIA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(2,691.01%) | (745.24%) | (148.29%) | (218.68%) | |
| (212.51%) | (225.54%) | (102.78%) | (136.67%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(1,268.92%) | (579.39%) | (83.64%) | (122.14%) | |
Average Days of Receivables |
0.00 | — | — | — | |
Free Cash Flow per Share |
(0.47) | (0.59) | (0.44) | (0.37) | |
Free Cash Flow |
(15.73) | (18.84) | (19.95) | (22.57) | |
| Other line items | |||||
Cash ROIC |
(143.89%) | (170.79%) | (32.09%) | (46.75%) | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(249,570.00) | — | — | — | |
Operating CF/Net income |
0.70 | 0.84 | 0.82 | 0.84 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.47) | (0.59) | (0.44) | (0.37) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates